SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS

Development of chemotherapeutic agent and boron carrying pharmaceutical based on HER2 specific targeted is important due to its role in enhancing cancer progression. The purpose of this study is to synthesize curcumin analogue, namely Pentagamaboron-0 (PGB-0) or 2,5-bis(4-boronic acid)benzylidine cy...

Full description

Bibliographic Details
Main Authors: Rohmad Yudi Utomo, Herwandhani Putri, Pudjono, Ratna Asmah Susidarti, Riris Istighfari Jenie, Edy Meiyanto
Format: Article
Language:English
Published: Universitas Gadjah Mada 2017-04-01
Series:Indonesian Journal of Pharmacy
Subjects:
Online Access:http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1183/813
_version_ 1818349781317058560
author Rohmad Yudi Utomo
Herwandhani Putri
Pudjono
Ratna Asmah Susidarti
Riris Istighfari Jenie
Edy Meiyanto
author_facet Rohmad Yudi Utomo
Herwandhani Putri
Pudjono
Ratna Asmah Susidarti
Riris Istighfari Jenie
Edy Meiyanto
author_sort Rohmad Yudi Utomo
collection DOAJ
description Development of chemotherapeutic agent and boron carrying pharmaceutical based on HER2 specific targeted is important due to its role in enhancing cancer progression. The purpose of this study is to synthesize curcumin analogue, namely Pentagamaboron-0 (PGB-0) or 2,5-bis(4-boronic acid)benzylidine cyclopentanone, and to explore the cytotoxic activity on HER2 overexpressed-cancer cells. MCF-7/HER2 was used as a model of HER2 overexpressed-cancer cells and NIH3T3 as normal cells. PGB-0 bound to ATP binding site of HER2 and EGFR based on molecular docking study. PGB-0 was synthesized resulting in 33% yield and was confirmed by IR, 1HNMR, 13CNMR and Mass spectroscopy. Based on MTT assay PGB-0 decreased cells viability on MCF-7/HER2 cells with IC50 value of 270 µM but performed no effect on NIH3T3 cells. Cell cycle analysis revealed that PGB-0 increased sub-G1 accumulation. PGB-0 decreased HER2 expression in a dose-dependent manner. We conclude that the new compound PGB-0 inhibits cell growth through cell death induction and decreased HER2 expression. Thus, PGB-0 is potential to be developed as a chemotherapeutic agent and boron carrying pharmaceutical targeted on the HER2 receptor.
first_indexed 2024-12-13T18:11:24Z
format Article
id doaj.art-203538e2ccef4b70b75b3efef8855a1e
institution Directory Open Access Journal
issn 2338-9427
2338-9486
language English
last_indexed 2024-12-13T18:11:24Z
publishDate 2017-04-01
publisher Universitas Gadjah Mada
record_format Article
series Indonesian Journal of Pharmacy
spelling doaj.art-203538e2ccef4b70b75b3efef8855a1e2022-12-21T23:35:57ZengUniversitas Gadjah MadaIndonesian Journal of Pharmacy2338-94272338-94862017-04-012827481http://dx.doi.org/10.14499/indonesianjpharm28iss2pp74SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLSRohmad Yudi Utomo0Herwandhani Putri1Pudjono2Ratna Asmah Susidarti3Riris Istighfari Jenie4Edy Meiyanto51Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 55281, Yogyakarta, Indonesia1Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 55281, Yogyakarta, IndonesiaDepartement of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 55281, Yogyakarta, IndonesiaDepartement of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 55281, Yogyakarta, IndonesiaDepartement of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 55281, Yogyakarta, IndonesiaDepartement of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 55281, Yogyakarta, IndonesiaDevelopment of chemotherapeutic agent and boron carrying pharmaceutical based on HER2 specific targeted is important due to its role in enhancing cancer progression. The purpose of this study is to synthesize curcumin analogue, namely Pentagamaboron-0 (PGB-0) or 2,5-bis(4-boronic acid)benzylidine cyclopentanone, and to explore the cytotoxic activity on HER2 overexpressed-cancer cells. MCF-7/HER2 was used as a model of HER2 overexpressed-cancer cells and NIH3T3 as normal cells. PGB-0 bound to ATP binding site of HER2 and EGFR based on molecular docking study. PGB-0 was synthesized resulting in 33% yield and was confirmed by IR, 1HNMR, 13CNMR and Mass spectroscopy. Based on MTT assay PGB-0 decreased cells viability on MCF-7/HER2 cells with IC50 value of 270 µM but performed no effect on NIH3T3 cells. Cell cycle analysis revealed that PGB-0 increased sub-G1 accumulation. PGB-0 decreased HER2 expression in a dose-dependent manner. We conclude that the new compound PGB-0 inhibits cell growth through cell death induction and decreased HER2 expression. Thus, PGB-0 is potential to be developed as a chemotherapeutic agent and boron carrying pharmaceutical targeted on the HER2 receptor.http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1183/813Synthesis of PGB-0MCF7/HER-2cytotoxic
spellingShingle Rohmad Yudi Utomo
Herwandhani Putri
Pudjono
Ratna Asmah Susidarti
Riris Istighfari Jenie
Edy Meiyanto
SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
Indonesian Journal of Pharmacy
Synthesis of PGB-0
MCF7/HER-2
cytotoxic
title SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
title_full SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
title_fullStr SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
title_full_unstemmed SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
title_short SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
title_sort synthesis and cytotoxic activity of 2 5 bis 4 boronic acid benzylidine cyclopentanone on her2 overexpressed cancer cells
topic Synthesis of PGB-0
MCF7/HER-2
cytotoxic
url http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1183/813
work_keys_str_mv AT rohmadyudiutomo synthesisandcytotoxicactivityof25bis4boronicacidbenzylidinecyclopentanoneonher2overexpressedcancercells
AT herwandhaniputri synthesisandcytotoxicactivityof25bis4boronicacidbenzylidinecyclopentanoneonher2overexpressedcancercells
AT pudjono synthesisandcytotoxicactivityof25bis4boronicacidbenzylidinecyclopentanoneonher2overexpressedcancercells
AT ratnaasmahsusidarti synthesisandcytotoxicactivityof25bis4boronicacidbenzylidinecyclopentanoneonher2overexpressedcancercells
AT ririsistighfarijenie synthesisandcytotoxicactivityof25bis4boronicacidbenzylidinecyclopentanoneonher2overexpressedcancercells
AT edymeiyanto synthesisandcytotoxicactivityof25bis4boronicacidbenzylidinecyclopentanoneonher2overexpressedcancercells